Status: Not yet recruiting
Randomized, Placebo-crontrolled Clinical Trial Evaluating the Efficacy and Safety of Heparan Sulfate 120 mg Prolonged-Release Tablets Compared With Placebo in Patients With Chronic Venous Disease
This multicenter, randomized, double-blind study is a phase III evaluates the safety and effectiveness of CLR prolonged-release tablets in patients with chronic venous insufficiency, has been shown to be effective in reducing the symptoms of itching, edema, spontaneous pain, and night cramps chronic venous disease.
Participants needed: 174
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Barbara MaglioneUpdated: Jul 6, 2026
Eligibility criteria
Participants with an age ≥ 18 and ≤ 80 years [+4]
Use of a venoactive drug in the last month [+30]